Literature DB >> 21215869

Where will new drugs come from?

.   

Abstract

Mesh：

Year:  2011        PMID： 21215869     DOI： 10.1016/S0140-6736(11)60001-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The new EU legislation on pharmacovigilance and changing models for drug development.

Authors:  Torbjörn Callréus
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

2.  Decline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UK.

Authors:  Derek J Ward; Orsolina I Martino; Sue Simpson; Andrew J Stevens
Journal:  BMJ Open       Date:  2013-02-20       Impact factor: 2.692

3.  Genomic markers to tailor treatments: waiting or initiating?

Authors:  Parvin Tajik; Patrick M Bossuyt
Journal:  Hum Genet       Date:  2011-04-13       Impact factor: 4.132

4.  How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012.

Authors:  Derek J Ward; Angharad Slade; Tracey Genus; Orsolina I Martino; Andrew J Stevens
Journal:  BMJ Open       Date:  2014-10-24       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.